RLFTF : Relief Therapeutics approaches topline data results

This should be an exiting week for Relief Therapeutic (OTC:RLFTF) investors. The company is expected to release topline data results and other information during the week for their Phase 2B/3 Trial of Zyesami. According to a previous release, no drug-related…